Metoclopramide for Post Traumatic Headache
Status: | Recruiting |
---|---|
Conditions: | Migraine Headaches |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/14/2017 |
Start Date: | August 1, 2017 |
End Date: | August 2019 |
A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache
Nearly 1.5 million patients present to US emergency departments annually following head
trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study
is to see if an intravenous medication called metoclopramide can improve the symptoms of
patients with acute post-traumatic headache.
trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study
is to see if an intravenous medication called metoclopramide can improve the symptoms of
patients with acute post-traumatic headache.
Inclusion Criteria:
Included patients will be adults who meet International Classification of Headache
Disorders criteria for acute post-traumatic headache. These are as follows:
- Traumatic injury to the head has occurred
- Headache has developed within 7 days of injury to the head
- Headache is not better accounted for by another diagnosis (eg, previous history of
migraine or tension-type headache)
The headache must be rated as moderate or severe in intensity at the time of initial
evaluation.
Exclusion Criteria:
Patients will be excluded if more than ten days have elapsed since the head trauma, if the
headache has already been treated with an anti-dopaminergic medication, or for medication
contra-indications including pheochromocytoma, seizure disorder, Parkinson's disease, use
of MAO inhibitors, and use of anti-rejection transplant medications.
We found this trial at
1
site
3550 Jerome Avenue
Bronx, New York 10467
Bronx, New York 10467
(718) 920-4321
Phone: 718-920-6626
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials